Clinical Trial Update: Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating a sodium-glucose cotransporter-2 (SGLT2) inhibitor in patients with acute cardiorenal syndrome (heart failure with acute kidne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Kidney Injury

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: Yale University | Conditions: Heart Failure, Acute Kidney Injury | Phase 2 | Status: RECRUITING